Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: Meta-analysis of randomized controlled trials

Simona Grozinsky-Glasberg, Abigail Fraser, Ethan Nahshoni, Abraham Weizman, Leonard Leibovici*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Context: In some patients symptoms of hypothyroidism persist despite therapy with T4. Objective: The objective of the study was to compare the effectiveness of T4-T3 combination vs. T4 monotherapy for the treatment of clinical hypothyroidism in adults. Data Sources: PubMed, EMBASE, LILACS, and the Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched in September 2005. References of all included trials were scanned for additional studies. We put no restrictions on language, year of publication, or publication status. Study Selection: All randomized trials that compared the effectiveness of T4-T3 combination vs. T4 monotherapy for the treatment of clinical hypothyroidism in adults were included. Data Extraction: The data were extracted by two independent reviewers. Data Synthesis: We included 11 studies, in which 1216 patients were randomized. No difference was found in the effectiveness of combination vs. monotherapy in any of the following symptoms: bodily pain [standardized mean difference (SMD) 0.00, 95% confidence interval (CI) -0.34, 0.35], depression (SMD 0.07, 95% CI -0.20, 0.34), anxiety (SMD 0.00, 95% CI -0.12, 0.11), fatigue (SMD -0.12, 95% CI -0.33, 0.09), quality of life (SMD 0.03, 95% CI -0.09, 0.15), body weight, total serum cholesterol, triglyceride levels, low-density lipoprotein, and high-density lipoprotein. Adverse events did not differ between regimens. Conclusions: T4 monotherapy should remain the treatment of choice for clinical hypothyroidism.

Original languageEnglish
Pages (from-to)2592-2599
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number7
DOIs
StatePublished - 2006

Fingerprint

Dive into the research topics of 'Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: Meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Cite this